 Presentations Highlight Continued Progress Across Expanded RD Pipeline of RASON Inhibitors and RAS Companion Inhibitors Presentations Highlight Continued Progress Across Expanded RD Pipeline of RASON Inhibitors and RAS Companion Inhibitors 